AI-Driven Assessment of The Efficacy And Safety of Gene and Cell-Based Therapies for Ischemic Heart Disease: A Systematic Review of Clinical Trials. JOC [Internet]. 2024 Dec. 25 [cited 2026 Jun. 24];23(1):1065-78. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1956